Smoking Still Takes a Heavy Toll in U.S.,... ( By Steven Reinberg HealthDay Rep...)

Smoking Still Takes a Heavy Toll in U.S., CDC Finds

Date:1/25/2013

By Steven Reinberg
HealthDay Reporter

FRIDAY, Jan. 25 (HealthDay News) -- Even though proven anti-smoking strategies exist, more than 440,000 Americans still die each year from cigarette smoking or exposure to secondhand smoke, federal health officials said Friday.

And 8.6 million suffer from serious smoking-related illnesses, the U.S. Centers for Disease Control and Prevention report.

One reason: the implementation of policies to deter smoking is spotty across the country, officials said.

"We are seeing a large geographic disparity in smoking developing," said Dr. Tim McAfee, director of CDC's Office on Smoking and Health. Regional differences existed 20 years ago, "but nothing like what we are seeing today," he noted.

For example, about twice as many people in Kentucky smoke as in Utah and California, he said. Lung cancer rates are starting to mirror this pattern too, with higher rates in the states with more smokers and faster-declining rates in states with fewer smokers, McAfee said.

The differences are likely based on "the degree to which states have instituted policies that either promote or don't promote keeping kids from starting and encouraging adults to quit," McAfee said.

Some states have strict anti-smoking laws and high cigarette taxes, while other states, such as Texas, have no tobacco laws, he said.

A proven, multi-pronged strategy to curb smoking combines higher tobacco taxes, smoke-free laws, media campaigns, limits on tobacco advertising and promotions and restricted access to tobacco products and programs, the CDC said.

Dollars spent by the states on these programs vary widely, and no state spends the total amount the CDC recommends.

Maine spends about 80 percent of the recommended amount on these programs, while Tennessee spends 1.1 percent of the recommended amount, McAfee said.

The new report is designed for state officials and others to assess sta
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Anti-tobacco TV ads help adults stop smoking, study finds
2. Exercise helps smokers to quit smoking, to remain smoke-free and to reduce the risk of death
3. Small neural focus groups predict anti-smoking ad success
4. Some women may be genetically predisposed to smoking-related hot flashes
5. Friends Parents Can Sway Teens Odds for Drinking, Smoking
6. Fewer Young Americans Smoking, Survey Finds
7. Vitamin C improves pulmonary function in newborns of pregnant smoking women
8. Genetic marker may predict smoking quantity in African Americans
9. 5 percent of workers gave up smoking when the anti-tobacco law took effect
10. Vitamin C improves lung function in newborns of pregnant smoking women
11. States Use Only Fraction of Tobacco Revenues to Fight Smoking, Study Finds

Post Your Comments:

Related Image:

Smoking Still Takes a Heavy Toll in U.S., CDC Finds

(Date:5/21/2013)... (PRWEB) May 21, 2013 AAG Health, ... in Miami, announced today that it has acquired the ... Physioquanta Group. , Using advanced spectrophotometry technology, the OligoScan ... bioavailability of up to 14 heavy metals, 20 trace ... of high toxic metal substances such as mercury, lead, ...

(Date:5/21/2013)... -- Racial disparities exist in the treatment of non-small ... according to a large new study. Although most ... their initial treatment, researchers found that blacks were less ... the early stages of the disease. Hispanics were more ... 2 disease than white patients. "In our study ...

(Date:5/21/2013)... PHILADELPHIA ─ A novel approach to obstructing the ... asthma has shown promise in a Phase IIa ... Their research will be presented at the American ... online in the New England Journal of ... tested the efficacy and safety of the monoclonal ...

(Date:5/21/2013)... This October, Phoenix, Arizona will host ... by Kolbe Corp, the Conation Nation Symposium ... inspire attendees to take action on these strengths in ... and 11th, will feature keynote speakers such as General ... Education for Kansas where Kolbe is widely used, and ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 Canadian-based FundRazr ... hot topic. Announced today, FundRazr has accumulated a list ... our $25 Million raised milestone this week. Among them ... that raised over $1 Million from video gamers, on-going ... Julian Assange, as well as Tiger Woods sending underserved ...

Breaking Medicine News(10 mins):Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 2 Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 3 Health News:Racial Disparities Seen in U.S. Lung Cancer Treatment 2 Health News:Monoclonal antibody appears effective and safe in asthma Phase IIa trial 2 Health News:Monoclonal antibody appears effective and safe in asthma Phase IIa trial 3 Health News:A New Destination for Thought Leaders - Kolbe Corp's Conation Nation Symposium 2

[0] AAG Health is the First Age Management Center in Florida to Offer the OligoScan [0] Racial Disparities Seen in U.S. Lung Cancer Treatment [0] Monoclonal antibody appears effective and safe in asthma Phase IIa trial [0] A New Destination for Thought Leaders - Kolbe Corp's Conation Nation Symposium [0] 25 Amazing Crowdfunding Stories Highlight FundRazr's $25 Million Milestone

... Annual Dinner, May 17, DETROIT, Jan. 31 ... its nurse paging system, thanks to the,generosity of ... vice,president of development for the Institute., (Logo:, ... our 26th Annual Dinner May 17, Ford Motor ...

... Long-time local partners cite proprietary research, strategic planning and ... superior creative as keys to their success, ... two major,national advertising awards at the Consumer Health World Conference ... have again taken top honors in a national awards program., ...

... once looked at for cancer, also attacks the human immunodeficiency ... research published today online in the open access journal Retrovirology. ... learned to hide out in certain human cells where it ... serve as viral reservoirs. Operating from these havens, the virus ...

... ABAX ), a medical products company manufacturing point-of-care,blood analysis ... 31, 2007., Highlights for the third ... $25.7 million, up 17% over last year,s comparable quarter. ... over last year,s comparable quarter. ...

... Separate Research Confirms Part D Seniors Also Enjoy Broad ... Pharmaceutical Care,Management Association (PCMA) issued the following statement on ... drug benefit is lower over the,next ten years than ... saving money without sacrificing beneficiaries,choice of prescription drugs. New ...

... of its ongoing efforts to do whatever it takes ... for Parkinson,s disease, The Michael J. Fox Foundation for ... total funding to four industry teams seeking to push ... awards were granted under MJFF,s Therapeutics Development Initiative (TDI) ...

Ford Motor Company Fund Continues Longtime Support to Cancer Care St.Vincent and Publicis Indianapolis Receive National Service Industry Advertising Awards Anti-parasite drug may provide new way to attack HIV Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 CMS: Part D Costs $117 Billion Lower Than Expected Michael J. Fox Foundation awards up to $3 million to industry teams

(Date:5/21/2013)... May 21, 2013 Accuray Incorporated ... publication of study results involving hundreds of prostate ... System, the most widely used form of prostate ... 304 patients for a median of 5 years, ... that 97 percent of patients with low-risk and ...

(Date:5/21/2013)... ORLANDO, Fla. , May 21, 2013 /PRNewswire/ ... and safety results from the global Phase 3 ... protease inhibitor simeprevir (TMC435) led to sustained virologic ... (SVR12) in 79 percent of treatment-experienced genotype 1 ... disease, including all stages of liver fibrosis, when ...

(Date:5/21/2013)... 21, 2013 Abaxis, Inc. (NasdaqGS: ABAX), a ... today that Martin Mulroy , chief ... Dental & Veterinary Conference on Wednesday, May 29, 2013 ... at Le Parker Meridien Hotel in New ... Abaxis develops, manufactures, markets and sells portable blood ...

Breaking Medicine Technology:New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2 New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3 Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2 Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3 Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4 Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5 Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6 Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7 Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2

[0] New Data Validates CyberKnife SBRT for Prostate Cancer Treatment [0] Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients [0] Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference

... Results from the Phase II portion of a ... for the treatment of acute heart failure will be ... at the American College of Cardiology,s (ACC) 58th Annual ... of medicine, University of California San Francisco , ...

... Will Test Ability of Adecatumumab to Prolong Disease ... MetastasesBETHESDA, Md., March 23 Micromet, ... company developing novel, proprietary antibodies for the treatment ... the commencement of a randomized, controlled phase 2 ...

Cached Medicine Technology:Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session 2 Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 2 Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 3 Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 4 Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 5

Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients

...

Tip is bent towards port for downward irrigation. 25G x 5/8in (.50 x 22mm)...

... product designed for LASIK surgery and other ... the corneal interface and/or stromal bed. Flattened ... and helps elevate the flap edge. Multiple ... G (.40 x 22mm). Angled 90 degrees, ...

... LASIK surgery and other types of ... corneal interface and/or stromal bed. Flattened ... flap and helps elevate the flap ... 23G x 7/8in (.60 x 22mm) ...

Medicine Products:

Hydrodissector - Daya Irrigating Cystotome - Reverse Lasik Irrigator - Probst Lasik Spatula/Irrigator